Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
March 15, 2006
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation
V T Ho, H T Kim, D Liney, et al.
Blood
|
August 9, 2001
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults
E P Hochberg, A C Chillemi, C J Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia
X F Yang, C J Wu, S McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome
E D Jacobsen, H T Kim, V T Ho, et al.
Leukemia
|
September 8, 2012
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome
J R Brown, H T Kim, P Armand, et al.
Blood
|
November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma
A S Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation
|
October 27, 2004
Routine screening for psychosocial distress following hematopoietic stem cell transplantation
S J Lee, F R Loberiza, J H Antin, et al.
Bone Marrow Transplantation
|
November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation
R L Haspel, G Kao, B Y Yeap, et al.
Bone Marrow Transplantation
|
January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
K E Abou-Nassar, K E Stevenson, J H Antin, et al.
Bone Marrow Transplantation
|
July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
R J Soiffer, A S Freedman, D Neuberg, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
March 15, 2006
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation
V T Ho, H T Kim, D Liney, et al.
Blood
|
August 9, 2001
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults
E P Hochberg, A C Chillemi, C J Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia
X F Yang, C J Wu, S McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome
E D Jacobsen, H T Kim, V T Ho, et al.
Leukemia
|
September 8, 2012
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome
J R Brown, H T Kim, P Armand, et al.
Blood
|
November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma
A S Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation
|
October 27, 2004
Routine screening for psychosocial distress following hematopoietic stem cell transplantation
S J Lee, F R Loberiza, J H Antin, et al.
Bone Marrow Transplantation
|
November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation
R L Haspel, G Kao, B Y Yeap, et al.
Bone Marrow Transplantation
|
January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
K E Abou-Nassar, K E Stevenson, J H Antin, et al.
Bone Marrow Transplantation
|
July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
R J Soiffer, A S Freedman, D Neuberg, et al.
Page
of 4